ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185 · see citing works

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Sniderman, A. D., Shapiro, S., Marpole, D. G. F., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 632 · see citing works

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., & Ference, B. A. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3780 · Cited by 593 · see citing works

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

Sampson, M. L., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R., Sethi, A. A., Fleming, J. K., Otvos, J. D., Meeusen, J. W., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0013 · Cited by 586 · see citing works

The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity

Borén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524 · see citing works

LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management

Cromwell, W. C., Otvos, J. D., Keyes, M. J., Pencina, M. J., SULLIVAN, L. M., Vasan, R. S., Wilson, P. W. F., & D’Agostino, R. B. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.10.001 · Cited by 428 · see citing works

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

Otvos, J. D., Mora, S., SHALAUROVA, I. Y., Greenland, P., Mackey, R. H., & Goff, D. C. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.001 · Cited by 385 · see citing works

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Johannesen, C. D. L., Mortensen, M. B., Langsted, A., & Nordestgaard, B. G. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.027 · Cited by 359 · see citing works

Introduction to Lipids and Lipoproteins

Feingold, K. R., & Grünfeld, C. (2015) · MDText.com, Inc. eBooks · Cited by 306 · see citing works

Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk

Ference, B. A., Kastelein, J. J. P., Ginsberg, H. N., Chapman, M. J., Nicholls, S. J., Ray, K. K., Packard, C. J., Laufs, U., Brook, R. D., Oliver-Williams, C., et al. (2017) · JAMA · doi:10.1001/jama.2017.11467 · Cited by 304 · see citing works

Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis

Marston, N. A., Giugliano, R. P., Melloni, G. E. M., Park, J.-G., Morrill, V., Blazing, M. A., Ference, B., Stein, E., Stroes, E. S., Braunwald, E., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2021.5083 · Cited by 262 · see citing works

Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events

Mora, S., Buring, J. E., & Ridker, P. M. (2014) · Circulation · doi:10.1161/circulationaha.113.005873 · Cited by 255 · see citing works

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00262-5 · Cited by 224 · see citing works

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data From UK Biobank

Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041149 · Cited by 191 · see citing works

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

Björnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183 · see citing works

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Glavinovic, T., Thanassoulis, G., Graaf, J. D., Couture, P., Hegele, R. A., & Sniderman, A. D. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025858 · Cited by 166 · see citing works

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C

Pencina, M. J., D’Agostino, R. B., Zdrojewski, T., Williams, K., Thanassoulis, G., Furberg, C. D., Peterson, E. D., Vasan, R. S., & Sniderman, A. D. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315569411 · Cited by 164 · see citing works

Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials

Thanassoulis, G., Williams, K., Ye, K., Brook, R., Couture, P., Lawler, P. R., de Graaf, J., Furberg, C. D., & Sniderman, A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000759 · Cited by 148 · see citing works

Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

Sniderman, A. D., Islam, S., Yusuf, S., & McQueen, M. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.039 · Cited by 138 · see citing works

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057807 · Cited by 118 · see citing works

Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention

Sniderman, A. D., Dufresne, L., Pencina, K. M., Bilgic, S., Thanassoulis, G., & Pencina, M. J. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae258 · Cited by 117 · see citing works

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

Soffer, D. E., Marston, N. A., Maki, K. C., Jacobson, T. A., Bittner, V. A., Peña, J. M., Thanassoulis, G., Martin, S. S., Kirkpatrick, C. F., Virani, S. S., et al. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.08.013 · Cited by 115 · see citing works

Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women

Lawler, P. R., Akinkuolie, A. O., Ridker, P. M., Sniderman, A. D., Buring, J. E., Glynn, R. J., Chasman, D. I., & Mora, S. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.264515 · Cited by 104 · see citing works

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Sniderman, A. D., Couture, P., Martin, S. S., DEGRAAF, J., Lawler, P. R., Cromwell, W. C., Wilkins, J. T., & Thanassoulis, G. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r082271 · Cited by 91 · see citing works

Excess Apolipoprotein B and Cardiovascular Risk in Women and Men

Johannesen, C. D. L., Langsted, A., Nordestgaard, B. G., & Mortensen, M. B. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.423 · Cited by 76 · see citing works

Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol

Björnson, E., Adiels, M., Gummesson, A., Taskinen, M., Burgess, S., Packard, C. J., & Borén, J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.034 · Cited by 69 · see citing works

Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: systematic review and meta-analysis of trials

Khan, S. U., Khan, M. U., Valavoor, S., Khan, M. S., Okunrintemi, V., Mamas, M. A., Leucker, T. M., Blaha, M. J., & Michos, E. D. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319871733 · Cited by 67 · see citing works

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

Contois, J. H., Langlois, M. R., Cobbaert, C. M., & Sniderman, A. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030405 · Cited by 57 · see citing works

Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA])

Tehrani, D. M., Zhao, Y., Blaha, M. J., Mora, S., Mackey, R. H., Michos, E. D., Budoff, M. J., Cromwell, W. C., Otvos, J. D., Rosenblit, P. D., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.03.040 · Cited by 56 · see citing works

The clinical utility of apoB versus LDL-C/non-HDL-C

Kohli-Lynch, C. N., Thanassoulis, G., Moran, A. E., & Sniderman, A. D. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.001 · Cited by 47 · see citing works

ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease

Morze, J., Melloni, G. E. M., Wittenbecher, C., Ala‐Korpela, M., Rynkiewicz, A., Guasch‐Ferré, M., Ruff, C. T., Hu, F. B., Sabatine, M. S., & Marston, N. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf207 · Cited by 41 · see citing works

Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis

Helgadottir, A., Thorleifsson, G., Snaebjarnarson, A., Stefansdottir, L., Sveinbjornsson, G., Tragante, V., Björnsson, E., Steinthorsdottir, V., Gretarsdottir, S., Helgason, H., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac219 · Cited by 30 · see citing works

Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non–HDL-C Levels

Sayed, A., Peterson, E. D., Virani, S. S., Sniderman, A. D., & Návar, A. M. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.1310 · Cited by 30 · see citing works

A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making

Cole, J., Otvos, J. D., & Remaley, A. T. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvac161 · Cited by 22 · see citing works

Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation

Johannesen, C. D. L., Mortensen, M. B., Nordestgaard, B. G., & Langsted, A. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119139 · Cited by 21 · see citing works

Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?

De Marco, D., Pencina, K., Pencina, M., Dufresne, L., Thanassoulis, G., & Sniderman, A. D. (2023) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2023.05.093 · Cited by 15 · see citing works

Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm

Varghese, B., Park, J., Chew, E., Sajja, A., Brownstein, A., Pallazola, V. A., Sathiyakumar, V., Jones, S. R., Sniderman, A. D., & Martin, S. S. (2021) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2020.09.011 · Cited by 12 · see citing works

Discordance analysis for apolipoprotein and lipid measures for predicting myocardial infarction in statin-treated patients with coronary artery disease: a cohort study

Li, T., Zhu, P., Song, Y., Tang, X., Gao, Z., Run-Lin, G. A. O., & Yuan, J. (2023) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2023.12.001 · Cited by 12 · see citing works

Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world

Murdock, D. J., Moll, K., Sanchez, R. J., Gu, J., Fazio, S., Geba, G. P., & Rodríguez, F. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100721 · Cited by 10 · see citing works

Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS

Fujino, M., Giovanni, G. D., Butters, J., Kataoka, Y., Hucko, T., Nelson, A. J., Nissen, S. E., Psaltis, P. J., & Nicholls, S. J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119145 · Cited by 10 · see citing works

Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)

Giannakopoulou, S., Antonopoulou, S., Barkas, F., Liberopoulos, E. N., Chrysohoou, C. A., Sfikakis, P. P., Pitsavos, C., Tsioufis, C., & Panagiotakos, D. B. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70077 · Cited by 8 · see citing works

Apolipoprotein Particle and Cardiovascular Risk Prediction (from a Prospective Cohort Study)

Su, X., Wang, M., Zuo, Y., Wen, J. A., Zhai, Q., Zhang, Y., Zhang, X., Li, Y., & He, Y. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.05.052 · Cited by 7 · see citing works

Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age

Kriemler, L. F., Rudin, S., Gawinecka, J., et al. (2024) · European Stroke Journal · doi:10.1177/23969873231221619 · Cited by 7 · see citing works

Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations

Cole, J., Couture, P., Tremblay, A. J., & Sniderman, A. D. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.09.009 · Cited by 6 · see citing works

Lipoprotein Heterogeneity and its Effect on Apolipoprotein Assays

Fruchart, J. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519009091086 · Cited by 11 · see citing works

Clinical significance of apolipoprotein B containing lipoprotein particles

Fruchart, J., Bard, J., Parra, H. J., et al. (1990) · Springer eBooks · doi:10.1007/978-94-009-0731-7_16

Lipoprotein Heterogeneity and its Effect on Apolipoprotein Assays

Fruchart, J. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519009091086 · Cited by 7 · see citing works

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

Hoogeveen, R. C., & Ballantyne, C. M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa252 · Cited by 316 · see citing works

Radioimmunoassay of human high density lipoprotein apoprotein A-I

FAINARU, M., Glangeaud, M. C., & Eisenberg, S. (1975) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(75)90286-x · Cited by 137 · see citing works